In the BioHarmony Drug Report Database

"Preview" Icon

Abivertinib

Abivertinib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target tyrosine-protein kinase JAK3, epidermal growth factor receptor, and tyrosine-protein kinase BTK.

 

Trade Name

 

 

Common Name

 

abivertinib
 

ChEMBL ID

 

CHEMBL4297865
 

Indication

 

 

Drug Class

 

Tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors

Image (chem structure or protein)

Abivertinib structure rendering